申请人:——
公开号:US20020188015A1
公开(公告)日:2002-12-12
In one embodiment, the present invention relates to compounds and compositions including pharmaceutical compositions containing the compounds and associated methods that uncouple sugar-mediated coupling of proteins, lipids, nucleic acids, and other biomaterials, and any combination thereof. In another embodiment, the compositions and associated methods have utility in vivo to reduce the deleterious effects of sugar-mediated coupling processes in an organism, when the organism is exposed to the compound or composition internally, by ingestion, transdermal application, or other means. In yet another embodiment, the compositions and associated methods are useful for the ex-vivo treatment of organs, cells and tissues and external treatment of hair, nails and skin to rejuvenate them by changing deformability and increase the tissue diffusion coefficient. In a further embodiment, the present invention relates to novel compounds and pharmaceutical compositions.
在一个实施例中,本发明涉及包含药物组合物的化合物和组合物,其中药物组合物包含这些化合物,并且相关方法解耦蛋白质、脂质、核酸和其他生物材料以及它们的任意组合的糖介导偶联。在另一个实施例中,这些组合物和相关方法在体内具有实用性,用于减少生物体暴露于内部摄入、经皮应用或其他方式的化合物或组合物时,糖介导偶联过程的有害影响。在另一个实施例中,这些组合物和相关方法对器官、细胞和组织的离体处理以及头发、指甲和皮肤的外部处理具有用处,通过改变可变性和增加组织扩散系数来使它们恢复活力。在另一个实施例中,本发明涉及新颖的化合物和药物组合物。